CANCER Final act of senescence

Spanish National Cancer Research Centre (CNIO), Madrid E28029, Spain.
Nature (Impact Factor: 42.35). 11/2011; 479(7374):481-2. DOI: 10.1038/479481a
Source: PubMed

ABSTRACT Damaged cells can initiate cancer. To avert this, faulty cells disable
their own propagation by undergoing senescence. But for full protection
against liver cancer, the senescent cells must be cleared by the immune
system. See Letter p.547

  • Source
    • "2013 ) . Paracrine effects of the SASP also provoke anti - tumor immunity ( Serrano 2011 ; Hoenicke and Zender 2012 ) . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cellular senescence is a stress response that accompanies stable exit from the cell cycle. Classically, senescence, particularly in human cells, involves the p53 and p16/Rb pathways, and often both of these tumor suppressor pathways need to be abrogated to bypass senescence. In parallel, a number of effector mechanisms of senescence have been identified and characterized. These studies suggest that senescence is a collective phenotype of these multiple effectors, and their intensity and combination can be different depending on triggers and cell types, conferring a complex and diverse nature to senescence. Series of studies on senescence-associated secretory phenotype (SASP) in particular have revealed various layers of functionality of senescent cells in vivo. Here we discuss some key features of senescence effectors and attempt to functionally link them when it is possible.
    Genes & development 01/2014; 28(2):99-114. DOI:10.1101/gad.235184.113 · 12.64 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AIDS is one of the most devastating diseases in human history. Decades of studies have revealed host factors required for HIV infection, indicating that HIV exploits host processes for its own purposes. HIV infection leads to AIDS as well as various comorbidities. The associations between HIV and human pathways and diseases may reveal non-obvious relationships between HIV and non-HIV-defining diseases. Human biological pathways were evaluated and statistically compared against the presence of HIV host factor related genes. All of the obtained scores comparing HIV targeted genes and biological pathways were ranked. Different rank results based on overlapping genes, recovered virus-host interactions, co-expressed genes, and common interactions in human protein-protein interaction networks were obtained. Correlations between rankings suggested that these measures yielded diverse rankings. Rank combination of these ranks led to a final ranking of HIV-associated pathways, which revealed that HIV is associated with immune cell-related pathways and several cancer-related pathways. The proposed method is also applicable to the evaluation of associations between other pathogens and human pathways and diseases. Our results suggest that HIV infection shares common molecular mechanisms with certain signaling pathways and cancers. Interference in apoptosis pathways and the long-term suppression of immune system functions by HIV infection might contribute to tumorigenesis. Relationships between HIV infection and human pathways of disease may aid in the identification of common drug targets for viral infections and other diseases.
    PLoS ONE 03/2012; 7(3):e34240. DOI:10.1371/journal.pone.0034240 · 3.53 Impact Factor
  • Epigenomics 04/2012; 4(2):119-23. DOI:10.2217/epi.12.1 · 5.22 Impact Factor
Show more